Naltrexone-bupropion (Mysimba) in management of obesity: A systematic review and meta-analysis of unpublished clinical study reports.

Onakpoya, Igho J; Lee, Joseph J; Mahtani, Kamal R; Aronson, Jeffrey K; Heneghan, Carl J

Onakpoya, Igho J; Lee, Joseph J; Mahtani, Kamal R; Aronson, Jeffrey K; Heneghan, Carl J.

Afiliación

Onakpoya IJ; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK.
Lee JJ; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK.
Mahtani KR; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK.
Aronson JK; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK.
Heneghan CJ; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK.

Br J Clin Pharmacol ; 86(4): 646-667, 2020 04.

Article en En | MEDLINE | ID: mdl-31918448

Asunto(s)

Bupropión; Naltrexona; Bupropión/efectos adversos; Combinación de Medicamentos; Humanos; Naltrexona/efectos adversos; Obesidad/tratamiento farmacológico

Palabras clave

clinical study report; meta-analysis; naltrexone-bupropion; obesity; systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Bupropión / Naltrexona Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google